BioMérieux team touts development of quicker sepsis Dx approach

Researchers at bioMérieux said they've developed a new, quicker and cheaper way to diagnose sepsis. Their method involves destroying white blood cells within a sample, centrifugation to collect bacteria or fungi from the sample and then fluorescence spectroscopy to analyze the fingerprint of pathogens carried by the sample. They said that their approach correctly identified species of bacteria or fungi in 96.5% of positive blood culture samples. The team said that the current approach to spotting bloodstream infections, which includes Gram staining, overnight subculture and then phenotypic ID tests, can be time-consuming, which often prevents quick treatment. Details of their research are published in mBio, the online open-access journal of the American Society for Microbiology. Item | Journal article

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.